The Influence of Beetroot Juice on Racial Disparities in Vascular Health

Blood Pressure Clinical Trial

Official title:

The Influence of Beetroot Juice on Racial Disparities in Vascular Health

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05132556
• Other study ID #: H22040
• Status: Completed
• Phase: N/A
• Start date: November 1, 2021
• Est. completion date: October 4, 2023

Study information

• Verified date: October 2023
• Source: Georgia Southern University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Black adults are 30% more likely to die from cardiovascular disease (CVD) compared to White adults, and more than half of this racial disparity in cardiovascular mortality may be attributed to the substantially greater prevalence of high blood pressure and vascular dysfunction in Black adults. Nitric oxide (NO) is a potent signaling molecule and key regular of vascular function that is suspected to be reduced in black individuals, but can be enriched by dietary nitrate (e.g., arugula, spinach, beets). The purpose of this study is to test the hypothesis that increasing NO bioavailability via nitrate-rich beetroot juice (BRJ) will lower blood pressure and improve vascular health in Black adults.

Description:

The investigators long-term research goal is to investigate mechanisms accounting for the higher prevalence of CVD and high blood pressure in Black individuals, and identify effective preventive strategies. Nitric oxide (NO) is a gaseous molecule that plays an essential role in the regulation of vascular tone and blood pressure regulation. Some, but not all, studies have observed reduced NO bioavailability in Black individuals, which may contribute to racial disparities in vascular health. Dietary nitrate supplementation using beetroot juice (BRJ) is demonstrated to increase circulating NO, lower blood pressure and arterial stiffness, and improve blood pressure regulation in clinical populations and health individuals. The central hypothesis is that increasing NO bioavailability by nitrate-rich BRJ supplementation will lower blood pressure and improve vascular health in Black adults. The investigators acknowledge that racial differences are not entirely driven by ancestry, and thus will assess and account for sociocultural factors and health behaviors (i.e., sleep, physical activity, and nutrition) that may contribute to racial health disparities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: October 4, 2023
• Est. primary completion date: May 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 39 Years

Eligibility

Inclusion Criteria:

• Between 18-39 years of age
• Body mass index (BMI) below 30 kg/m^2
• Free from signs or symptoms of neurologic, cardiovascular (e.g., heart attack, stroke, heart failure, arrhythmia), metabolic, and/or renal disease
• Have a blood pressure no lower than 90/50 mmHg
• Are not currently smoking, using smokeless tobacco, nor smoked within the past 12 months

Exclusion Criteria:

• Low blood pressure - less than 90/50 mmHg
• History of cardiovascular disease
• History of cancer
• History of diabetes
• History of kidney disease
• Obesity (BMI > 30 kg/m^2)
• Smoking or tobacco use
• Current pregnancy
• Nursing mothers
• Communication barriers

Related Conditions & MeSH terms

• Blood Pressure
• Cardiovascular Risk Factor
• Racial Disparities

Intervention

Other:
• Acute Beetroot Juice
Participants will ingest a beetroot juice supplement with and without inorganic nitrate to determine the effects of acute dietary nitrate ingestion on blood pressure and arterial stiffness

Locations

Country	Name	City	State
United States	Biodynamics and Human Performance Center	Savannah	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
Georgia Southern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in nitric oxide (NO) metabolites	The investigators will use chemiluminescence detection to measure salivary and circulating NO metabolites (nitrate and nitrate).	Baseline and two hours after beetroot juice ingestion, both conditions (experimental and control)
Primary	Changes in blood pressure	The investigators will use the SphygmoCor XCEL system to assess pulse wave analysis (PWA), which will provide brachial and aortic blood pressures (mmHg).	Baseline and two hours after beetroot juice ingestion, both conditions (experimental and control)
Primary	Changes in arterial stiffness	The investigators will use the SphygmoCor XCEL system to assess pulse wave velocity (PWV). A high-fidelity strain-gauge transducer is used to obtain the pressure waveform at the carotid pulse. Distances from the carotid artery sampling site to the femoral artery (upper leg instrumented with a thigh cuff for oscillometric sphygmomanometry), and from the carotid artery to the suprasternal notch will be recorded. PWV will be expressed as m/s.	Baseline and two hours after beetroot juice ingestion, both conditions (experimental and control)
Primary	Changes in blood pressure responses to stress	The investigators will use the SphygmoCor XCEL system to assess pulse wave analysis (PWA) at rest and during handgrip exercise and after exercise during cuff occlusion.	Baseline and two hours after beetroot juice ingestion, both conditions (experimental and control)
Primary	Changes in arterial stiffness responses to stress	The investigators will use the SphygmoCor XCEL system to assess pulse wave velocity (PWV) at rest and during handgrip exercise and after exercise during cuff occlusion.	Baseline and two hours after beetroot juice ingestion, both conditions (experimental and control)
Secondary	Objective sleep duration	ActiGraph GT9X accelerometers will be used to quantify sleep duration. Participants will wear the watch unit for 7 days. The investigators will assess qualitative sleep scores and cross-check actigraphy wear times with a sleep diary.	Baseline (pre-intervention)
Secondary	Subjective sleep quality	The investigators will use the Pittsburgh Sleep Quality Index (0-21, higher value indicating worse sleep) to assess subjective indices of sleep health.	Baseline (pre-intervention)
Secondary	Physical activity	Participants will wear an ActiGraph GT9X accelerometer for seven days to objectively quantify time spent in moderate-vigorous physical activity.	Baseline (pre-intervention)
Secondary	Habitual dietary intake	The investigators will instruct participants to complete a diet log for three days which will be characterized with Nutrition Data System for Research (NSDR).	Baseline (pre-intervention)
Secondary	Social determinants of health	The investigators will use the Perceived Ethic Discrimination Questionnaire (22-154, higher value indicating more experiences of ethnic discrimination/racism) to quantify social determinants of health.	Baseline (pre-intervention)
Secondary	Economic determinants of health	The investigators will use the Socioeconomic Status (0-32, lower score indicating lower socioeconomic status) questionnaire to quantify economic determinants of health.	Baseline (pre-intervention)